Last reviewed · How we verify
PPMX-T003
At a glance
| Generic name | PPMX-T003 |
|---|---|
| Sponsor | Hiroshima University Hospital |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Safety Evaluation Study for Patients With Aggressive NK-cell Leukemia (PHASE1, PHASE2)
- Safety Evaluation Study for Patients With Polycythemia Vera (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |